In today’s podcast, we examine mental well-being during COVID-19, how society is coping, and the long-term ramifications of the pandemic. Full year of the pandemic and the rolling lockdowns was hard on all of us. And it brought the subject of mental wellness to center stage. The pandemic led to isolation. For others, it was joblessness and more.
Digital technology companies are looking to solve some of the world’s largest healthcare issues such as diabetes, congestive heart failure, obesity and Alzheimer’s. In this episode we speak with experts on the front line of blending technology with healthcare and social change.
This episode explores how artificial intelligence and machine learning allow biopharmaceutical companies to quickly and cost-effectively bring new products to market. This exciting new technology unlocks the door for discovering therapies in rare diseases and other unmet medical conditions that were once too costly and time consuming to develop.
The RP HealthCast is back! In our season two premiere, we speak with a scientist, researcher, and medical journalist about the devastating effects experienced by “long-haulers” — a growing group of people who still suffer from COVID-19 symptoms months after being infected.
The RP HealthCast returns in 2021 with a fresh format, featuring captivating stories from innovators, journalists, medical professionals, and more! In each episode our host, Jeffrey Freedman, goes beyond the headlines to explore different perspectives and discuss varying viewpoints on the latest advancements in technology and health. Please stay tuned for our first episode premiering next week.
In this week’s episode, we speak with Zachary Brennan of Politico about the newly approved coronavirus vaccines, their distribution plans, and how these advances are poised to change the course of the pandemic.
In this week’s episode, we speak with Dr. Cathy Faye, the Executive Director of the Cummings Center for the History of Psychology at the University of Akron, about how dangerous unsubstantiated rumors and misinformation can be to society — especially in the context of a global pandemic.
In this week's episode, we speak with medical journalist, Charlotte Huff, about the mental and physical hardships that nurses are facing as the coronavirus pandemic appears to be entering its deadliest phase.
In this week’s episode, we speak with Lisa Gill from Consumer Reports about the ever increasing trend of unpaid medical debt in America. Lisa discusses real-life scenarios, what to look for on your bills, what to ask for when getting treatment, and who you can go to if you get overburdened with costs.
In this week’s episode, we speak with Brandon May, a NYC-based medical journalist and writer, about how the healthcare industry has had to quickly evolve to meet the needs of patients during the pandemic.
In this week’s episode, we speak with Elizabeth Bernstein of The Wall Street Journal about how to strengthen and nurture our relationships with family, friends, and even ourselves during these turbulent times.
In this week’s episode we speak with Lauren Young from Reuters about technology and working from home. Depending on your stage of life, your family situation and your access to technology, remote work has required quite a significant learning curve, and, in some cases, it presents a hardship
In this week’s episode we speak with Monique Brouillette, from Scientific American who explains the varying stages a patient may go through after contracting the novel coronavirus — and the importance of receiving the proper treatment at each critical phase.
In this week’s episode we speak with Kimberly Leonard, senior reporter for Business Insider, about the upcoming Supreme Court hearing on the constitutionality of the ACA and what the ruling could mean for the US healthcare system.
In this week’s episode we speak with science writer, author, educator and photojournalist, Tara Haelle, to discuss the vaccine approval process and how political meddling could undermine the public’s perception of a coronavirus vaccine and their willingness to get it.
In this week's episode, we speak with Andrew Dunn from Business Insider to discuss the COVID vaccine timetable; who are the players, who are the front runners, and when will a vaccine be made available to the general public.
In this week’s episode we speak with Larry Light, editor for Chief Investment Officer and writer for Forbes.com, to discuss how the current political and economic turbulence influence the markets and what socioeconomic variables create the largest volatility.
Brian Bremner, Executive Editor of Global Business for Bloomberg News discusses how the largest countries in the world have responded to the pandemic. With the US having more than 20% of the deaths worldwide, what are we doing wrong in containing COVID-19, and which countries are leading the way in doing it right?
In this week’s episode we speak with Claudia Wallis, an award-winning health journalist for Scientific American, about what it is about a person’s genetic make-up that could make them more at risk to COVID-19 than others.
While still categorized as a Schedule 1 substance—and not approved by the FDA—some form of cannabis is legal in more than 60% of the country. In this week’s episode, we speak with Anthony Noto from Benzinga, where he gets into the weeds of this multi-billion dollar industry and the issues it faces.